您的购物车当前为空
A-395 是一种多梳抑制复合物 2 (PRC2) 蛋白质-蛋白质相互作用的拮抗剂,可有效抑制三聚体 PRC2 复合物 (EZH2-EED-SUZ12),IC50为 18 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
A-395 是一种多梳抑制复合物 2 (PRC2) 蛋白质-蛋白质相互作用的拮抗剂,可有效抑制三聚体 PRC2 复合物 (EZH2-EED-SUZ12),IC50为 18 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,820 | In Stock | |
| 5 mg | ¥ 6,430 | In Stock | |
| 10 mg | ¥ 8,670 | In Stock | |
| 25 mg | ¥ 12,800 | In Stock | |
| 50 mg | ¥ 17,300 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 6,930 | In Stock |
A-395 相关产品
| 产品描述 | A-395 is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions that potently inhibits the trimeric PRC2 complex (EZH2-EED-SUZ12, IC50: 18 nM). |
| 靶点活性 | PRC2:18 nM |
| 体外活性 | 胚胎外胚层发育(EED)蛋白是PRC2的一个关键亚基。A-395拮抗EED的H3K27me3结合功能。它与EED的H3K27me3结合口袋结合,进而阻止PRC2催化活性的异构体激活。A-395能够与H3K27me3肽竞争性地结合到EED(IC50:7 nM)。A-395能在细胞中调节PRC2的活性,通过高效降低H3K27甲基化标记以高度选择性的方式,而它的近似化学类似物A-395N则不行。A-395处理抑制了H3K27me2和H3K27me3(IC50s:390 nM和90 nM),并且导致对SAM-竞争性EZH2抑制剂敏感的人类肿瘤细胞系的生长抑制。 |
| 细胞实验 | 1,000 multiple myeloma cells are seeded in each well of 96-well cell culture plates and treated with A-395 (0.001-100 μM) or DMSO control for 10 d before the cell proliferation assay. Cell proliferation assays are conducted with the CellTiter-Glo Luminescent Cell Viability Assay. |
| 分子量 | 486.65 |
| 分子式 | C26H35FN4O2S |
| CAS No. | 2089148-72-9 |
| Smiles | CN(C)[C@H]1CN(C[C@@H]1c1ccc(cc1)N1CCN(CC1)S(C)(=O)=O)C1CCc2cccc(F)c12 |
| 密度 | 1.30 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (205.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容